Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease (Q38711424)

5 September 2017

Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease (English)

1 reference

5 September 2017

cardiovascular disease

1 reference

metabolic dysfunction–associated steatotic liver disease

inferred from title

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809873%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Stefano Ballestri

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809873%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Amedeo Lonardo

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809873%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

4

Giovanni Targher

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809873%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

publication date

25 January 2016

1 reference

Digestive Diseases and Sciences

5 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809873%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809873%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

1246-1267

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809873%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26809873%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10620-016-4040-6

11 June 2020

exact match

0 references

cites work

From NAFLD in clinical practice to answers from guidelines

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

NAFLD: a multisystem disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Extrahepatic complications of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Non-alcoholic fatty liver disease is independently associated with left ventricular hypertrophy in hypertensive Type 2 diabetic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Impaired left ventricular mechanics in nonalcoholic fatty liver disease: a speckle-tracking echocardiography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Cardiac structure and function are altered in type 2 diabetes and non-alcoholic fatty liver disease and associate with glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Left atrial deformation parameters in patients with non-alcoholic fatty liver disease: a 2D speckle tracking imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Nonalcoholic Fatty Liver Disease Is Independently Associated with Early Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: association with the severity of liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Nonalcoholic Steatohepatitis Score is an Independent Predictor of Right Ventricular Dysfunction in Patients with Nonalcoholic Fatty Liver Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Association of Nonalcoholic Fatty Liver Disease with Subclinical Cardiovascular Changes: A Systematic Review and Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Left ventricular function by echocardiography, tissue Doppler imaging, and carotid intima-media thickness in obese adolescents with nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Association between nonalcoholic fatty liver disease and cardiovascular risk in obese children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Alterations in ventricular structure and function in obese adolescents with nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Left ventricular dysfunction in obese children and adolescents with nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Serum gamma-glutamyl transferase and risk of heart failure in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Γ-glutamyltransferase, hepatic enzymes, and risk of incident heart failure in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Serum γ-glutamyltransferase and the risk of heart failure in men and women in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Hepatic steatosis is associated with aortic valve sclerosis in the general population: the Study of Health in Pomerania (SHIP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Nonalcoholic fatty liver disease is associated with aortic valve sclerosis in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Heart valve calcification in patients with type 2 diabetes and nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Aortic-valve stenosis--from patients at risk to severe valve obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Aortic and mitral annular calcifications are predictive of all-cause and cardiovascular mortality in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Heart valve sclerosis predicts all-cause and cardiovascular mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Mitral annular calcification predicts cardiovascular morbidity and mortality: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Global epidemiology of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Relation of circulating liver transaminase concentrations to risk of new-onset atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Circulating levels of liver enzymes and incidence of atrial fibrillation: the Atherosclerosis Risk in Communities cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Prolonged QTc interval and risk of sudden cardiac death in a population of older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Electrocardiographic repolarization complexity and abnormality predict all-cause and cardiovascular mortality in diabetes: the strong heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Nonalcoholic Fatty Liver Disease Is Associated With QT Prolongation in the General Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Inflammation and the pathogenesis of atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Markers of inflammation and coronary artery calcification: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Fatty liver, insulin resistance, and features of metabolic syndrome: relationships with coronary artery calcium in 10,153 people

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Nonalcoholic fatty liver disease is associated with coronary artery calcification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Higher association of coronary artery calcification with non-alcoholic fatty liver disease than with abdominal obesity in middle-aged Korean men: the Kangbuk Samsung Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Fatty liver, abdominal adipose tissue and atherosclerotic calcification in African Americans: the Jackson Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Association of coronary artery calcification with hepatic steatosis in asymptomatic individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Sonographic fatty liver, overweight and ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Hepatic steatosis and cardiovascular disease outcomes: An analysis of the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Ultrasonography-diagnosed non-alcoholic fatty liver disease is not associated with prevalent ischemic heart disease among diabetics in a multiracial Asian hospital clinic population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Association between nonalcoholic fatty liver disease and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Nonalcoholic fatty liver disease is associated with coronary artery disease in Koreans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Nonalcoholic fatty liver disease is associated with significant coronary artery disease in type 2 diabetic patients: a computed tomography angiography study 2：.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Nonalcoholic fatty liver in nondiabetic patients with acute coronary syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Sonographic evaluation for predicting the presence and severity of coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Evaluation of vulnerable coronary plaques and non-alcoholic fatty liver disease (NAFLD) by 64-detector multislice computed tomography (MSCT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

High-risk coronary plaque at coronary CT angiography is associated with nonalcoholic fatty liver disease, independent of coronary plaque and stenosis burden: results from the ROMICAT II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Nonalcoholic Hepatic Steatosis Is a Strong Predictor of High-Risk Coronary-Artery Plaques as Determined by Multidetector CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Impact of Nonalcoholic Fatty Liver Disease on Myocardial Perfusion in Nondiabetic Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Non-alcoholic fatty liver disease and risk of in-stent restenosis after bare metal stenting in native coronary arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Circulating Markers of Liver Function and Cardiovascular Disease Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Natural course of nonalcoholic fatty liver disease in southern China: a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

The Framingham risk score and heart disease in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Natural history of hepatic steatosis: observed outcomes for subsequent liver and cardiovascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Long term prognosis of fatty liver: risk of chronic liver disease and death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Long-term follow-up of patients with NAFLD and elevated liver enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Long-term follow-up of patients with nonalcoholic fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Decreased survival of subjects with elevated liver function tests during a 28-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Diagnosis and management of nonalcoholic fatty liver disease and its hemostatic/thrombotic and vascular complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Endocrine and liver interaction: the role of endocrine pathways in NASH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

PNPLA3 I148M polymorphism and progressive liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

The dual and opposite role of the TM6SF2-rs58542926 variant in protecting against cardiovascular disease and conferring risk for nonalcoholic fatty liver: A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Age, abdominal obesity, and glycated hemoglobin are associated with carotid atherosclerosis in type 2 diabetes patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Inter-organ communication in the regulation of lipid metabolism: focusing on the network between the liver, intestine, and heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Microbiota and diabetes: an evolving relationship.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

The human gut microbiome: a review of the effect of obesity and surgically induced weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Gut microbiome, obesity, and metabolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Systematic review: microbial dysbiosis and nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Transmission of atherosclerosis susceptibility with gut microbial transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Gut feelings about heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Far from the eyes, close to the heart: dysbiosis of gut microbiota and cardiovascular consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

The contributory role of gut microbiota in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Mitochondrial abnormalities in non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Intramitochondrial crystalline inclusions in nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Mitochondrial cytopathies and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Cardiovascular remodelling in coronary artery disease and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Insulin resistance and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

NASH (Nonalcoholic steatohepatitis): A case of multiorganelle failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Fatty liver, carotid disease and gallstones: a study of age-related associations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

The efficacy and safety of statins for the treatment of non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Potential for statins in the chemoprevention and management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Statin use and non-alcoholic steatohepatitis in at risk individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Sterile inflammation in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Lysosomal cholesterol accumulation: driver on the road to inflammation during atherosclerosis and non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Pericardial fat is independently associated with human atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Echocardiographic epicardial fat thickness and coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Human epicardial adipose tissue is a source of inflammatory mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Assessment of risk factors for developing incident aortic stenosis: the Tromsø Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Interaction of age with lipoproteins as predictors of aortic valve calcification in the multi-ethnic study of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Effect of rosuvastatin on C-reactive protein and progression of aortic stenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Increased levels of systolic blood pressure within the normal range are associated with significantly elevated risks of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Visceral adipose tissue area as an independent risk factor for elevated liver enzyme in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the Heart and Soul Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Fetuin-A negatively correlates with liver and vascular fibrosis in nonalcoholic fatty liver disease subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Meta-analysis of left ventricular hypertrophy and sustained arrhythmias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Association between noninvasive fibrosis markers and cardio-vascular organ damage among adults with hepatic steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Influence of non-alcoholic fatty liver disease on autonomic changes evaluated by the time domain, frequency domain, and symbolic dynamics of heart rate variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Body composition and body fat distribution are related to cardiac autonomic control in non-alcoholic fatty liver disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Resistance exercise improves autonomic regulation at rest and haemodynamic response to exercise in non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Alanine aminotransferase predicts coronary heart disease events: A 10-year follow-up of the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Electrophysiological, Electroanatomical, and Structural Remodeling of the Atria as Consequences of Sustained Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-016-4040-6

Statins, Rho GTPases and KLF2: new mechanistic insight into liver fibrosis and portal hypertension

21 January 2018

1 reference

12 December 2020

Perspectives on cellular dysfunction in nonalcoholic steatohepatitis: a case of 'multiorganelle failure'? Proceedings of a virtual workshop on nonalcoholic steatohepatitis

1 reference

12 December 2020

In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not

1 reference

12 December 2020

Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes

1 reference

12 December 2020

Long-term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: A prospective cohort study

1 reference

12 December 2020

Doppler Tissue Evaluation of Atrial Conduction Properties in Patients With Non-alcoholic Fatty-liver Disease

1 reference

12 December 2020

Non-alcoholic fatty liver disease, metabolic syndrome and subclinical cardiovascular changes in the general population

1 reference

12 December 2020

The synergistic impact of nonalcoholic fatty liver disease and metabolic syndrome on subclinical atherosclerosis

1 reference

12 December 2020

NAFLD. Accurate quantification of hepatic fat--is it important?

1 reference

12 December 2020

Association between non-alcoholic fatty liver disease and autonomic dysfunction in a Chinese population

1 reference

12 December 2020

Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: association with liver fibrosis

1 reference

12 December 2020

If steatosis is the atherosclerosis of the liver, are statins the "aspirin" for steatosis?

1 reference

12 December 2020

Prognosis of patients with a diagnosis of fatty liver--a registry-based cohort study.

1 reference

12 December 2020

Ectopic fat depots and left ventricular function in nondiabetic men with nonalcoholic fatty liver disease

1 reference

12 December 2020

Nonalcoholic fatty liver disease, cardiovascular outcomes, and mortality in patients undergoing a coronary angiogram

1 reference

12 December 2020

Hepatic FDG uptake is associated with future cardiovascular events in asymptomatic individuals with non-alcoholic fatty liver disease

1 reference

12 December 2020

Impairment of the left ventricular systolic and diastolic function in patients with non-alcoholic fatty liver disease

1 reference

12 December 2020

Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes

1 reference

12 December 2020

Relation of proinflammatory activity of epicardial adipose tissue to the occurrence of atrial fibrillation

1 reference

12 December 2020

Association of NAFLD with subclinical atherosclerosis and coronary-artery disease: meta-analysis

1 reference

12 December 2020

Evaluation of ultrasonographic fatty liver and severity of coronary atherosclerosis, and obesity in patients undergoing coronary angiography.

1 reference

12 December 2020

[Diabetes mellitus; auricular fibrillation; arteriosclerosis obliterans of the legs; gangrene of the 1st and 2d toes of the right foot; fatty degeneration of the liver]

1 reference

12 December 2020

Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue Doppler imaging assessment

1 reference

12 December 2020

Early left ventricular abnormality/dysfunction in obese children affected by NAFLD

1 reference

12 December 2020

Impaired myocardial perfusion reserve in patients with fatty liver disease assessed by quantitative myocardial perfusion magnetic resonance imaging

1 reference

12 December 2020

Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease

1 reference

12 December 2020

Non-alcoholic fatty liver disease and risk of cardiovascular disease.

1 reference

12 December 2020